The Association’s mission is to advance, for the public benefit, the science, art and practice of orthopaedic surgery with the aim of bringing relief to patients of all ages suffering from the effects of injury or disorders of the musculoskeletal system.
We provide good practice guides across all areas of trauma and orthopaedic surgery, many of which have a global reputation for excellence. By engaging proactively with the Government, our advice on musculoskeletal services and the future trauma and orthopaedic workforce carries weight. It influences developments on the ground, notwithstanding the recent dilution of policy expertise in the Department of Health. This effect is further multiplied by our membership of the Arthritis & Musculoskeletal Alliance (ARMA), the fact that we work closely with orthopaedic Clinical Directors across the NHS, our relationship with the healthcare and pharmaceutical industries, together with our European and international contacts. We are also most fortunate to benefit from the support and challenge of a highly motivated Patient Liaison Group. Lastly, we engage extensively with the medico-legal community in this important area of orthopaedic practice.
Training and Education
We design the surgical training curriculum for trauma and orthopaedics, together with the syllabus of education that sits beneath it. To do that effectively we focus on standards and delivery, working in close collaboration with Training Programme Directors in each area of the NHS and our own Trainees’ Association. We advise on standards of revalidation for surgeons, run instructional courses for Consultants, Staff and Associate Specialist Grades and Trainees alike. We also mount an annual scientific congress with a comprehensive programme synchronised to the future five year revalidation cycle. Our fellowship programme is comprehensive and benefits from trust and generous industry sponsorship.
We have moved away from direct funding of small research grants (pump-priming) and are concentrating our resources on infrastructure and facilitating future research, where we believe we can create a bigger and longer-lasting impact. We continue to raise funds for these infrastructure activities, in particular the BOA Orthopaedic Surgery Research Centre based at York Trials Unit. We also support the James Lind Alliance; forming Priority Setting Partnerships (PSPs) to identify and prioritise the top ten ‘unanswered questions’ about the effects of treatments.
Funding these initiatives has been made possible by donations from many of our members and also from external donors through Joint Action – the Orthopaedic Research Appeal of the BOA.